Answers are grounded in this paper and cite their sources.
Idiopathic nephrotic syndrome (INS) is the most frequent glomerular disorder in children, yet its etiology remains unclear. Growing evidence implicates gut microbiome dysbiosis in its pathogenesis, but comprehensive multi-kingdom microbiome studies are lacking. We conducted a prospective metagenomic analysis of the gut bacteriome, virome, mycobiome, and archaeome in children with INS at different disease phases (onset, remission, and relapse) and in healthy controls using whole genome shotgun sequencing. Microbial composition, interkingdom interactions, bacterial secretion systems, and metabolic pathways were evaluated alongside clinical and biochemical profiling in relationship to disease phases. A total of 117 participants were enrolled, including 77 INS patients (mean age 7.21 ± 0.43 years; 53 males (68.8) and 24 females (31.2%) and 40 healthy controls (mean age 8.4 ± 0.7 years, 25 males (62.5%) and 15 females (37.5%), with stool samples collected from INS during remission ( n = 48), relapse ( n = 29), and disease onset ( n = 7) and 40 from controls. INS patients exhibited profound gut dysbiosis, characterized by a significant reduction in the bacterial richness and depletion of butyrate producing bacteria Faecalibacterium prausnitzii as well as beneficial bacteria Bifidobacterium breve and Pseudomonas mendocina compared with healthy controls. Enrichment of Bacteroides coprophilus, Porphyromonas endodontalis, and Aliivibrio salmonicida strongly associated with disease activity. A fungal shift was also observed as Encephalitozoon inte and Eremothecium gossypii were the dominated fungal species at the disease onset, while Podospora anserina and Pongo a belii were more prominent at relapse. Archaeome analysis revealed a reduction of methanogens like and enrichment of Mettalsphaera sedula in INS patients. Virome profiling showed a notable increase in crAssphage. Functional profiling identified altered metabolic pathways, including upregulated pyochelin biosynthesis and downregulated short chain fatty acid (SCFA) production in INS patients. Interkingdom network analysis revealed a marked reduction in microbial interkingdom interactions in INS patients, showing only 209 interactions compared to 576 interactions in healthy controls, with shifting the central connection hub from Bacteroides fragilis (with 16 interactions in controls) to Methanococcoides burtonii, Coccidioides immitis, Coprinopsis cinerea (with 6 interactions only in INS patients). INS patients with active disease states (onset and relapse) harbor a unique multi-kingdom metagenomic signature characterized by blunted microbial crosstalk and pathogenic functional shifts. These findings position the gut microbiome as a potential contributor to INS pathogenesis and as a therapeutic target.
No takes yet. Share an insight, caveat, or question.
Wehedy et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: